Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000183480 | SCV000235940 | uncertain significance | not provided | 2020-07-23 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV000700883 | SCV000829659 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2023-07-29 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 201806). This variant has not been reported in the literature in individuals affected with JUP-related conditions. This variant is present in population databases (rs782460555, gnomAD 0.006%). This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 24 of the JUP protein (p.Ser24Leu). |
Fulgent Genetics, |
RCV000700883 | SCV002775468 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV000183480 | SCV005196706 | uncertain significance | not provided | 2022-05-27 | criteria provided, single submitter | clinical testing |